Option Care Health (NASDAQ:OPCH) Upgraded to “Buy” at Jefferies Financial Group

Jefferies Financial Group upgraded shares of Option Care Health (NASDAQ:OPCH) from a hold rating to a buy rating in a report released on Thursday morning, MarketBeat.com reports. They currently have $35.00 price objective on the stock, up from their previous price objective of $26.00.

Several other equities analysts have also recently weighed in on OPCH. UBS Group began coverage on Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective for the company. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and boosted their price target for the company from $26.00 to $33.00 in a research note on Monday, January 13th. JMP Securities reiterated a “market outperform” rating and set a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Barrington Research boosted their target price on shares of Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a research report on Tuesday, January 14th. Finally, Truist Financial reduced their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $31.14.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH opened at $30.00 on Thursday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health has a 12-month low of $21.39 and a 12-month high of $34.63. The company’s 50 day moving average price is $24.10 and its two-hundred day moving average price is $27.78. The firm has a market cap of $5.11 billion, a PE ratio of 25.21, a PEG ratio of 2.12 and a beta of 1.31.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The shares were bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 0.64% of the stock is owned by corporate insiders.

Institutional Trading of Option Care Health

A number of hedge funds have recently made changes to their positions in OPCH. UMB Bank n.a. raised its holdings in Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after buying an additional 750 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after acquiring an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. lifted its holdings in shares of Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after purchasing an additional 1,446 shares during the period. International Assets Investment Management LLC grew its stake in shares of Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after purchasing an additional 2,757 shares during the last quarter. Finally, Quarry LP increased its holdings in Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after purchasing an additional 2,628 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.